Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-05-06

Clinical Trial Update: Investigation of Eluxadoline for Diabetic Diarrhea [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating eluxadoline for diabetic diarrhea was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eluxadoline (eluxadoline)

Snippet

Sponsor: Temple University | Conditions: Diabetic Diarrhea, Diabetes | Phase 2, Phase 3 | Status: WITHDRAWN